Search Results 601-610 of 16282 for pharmacogenetics
In a recent paper published in Gastroenterology, Mayo Clinic scientists found the G9a enzyme, a regulator of gene expression, may inhibit inflammatory ...
Preeclampsia linked to increased markers of brain cell damage, inflammation featured image · Expert Alert: Options for laryngeal regeneration featured image.
The purpose of this study is to offer pre-approval drug access of iniparib combined with gemcitabine and carboplatin, in order to provide potential clinical ...
Consultations are available online or by phone with a Mayo Clinic expert in genetic testing or long QT syndrome and conditions that may lead to sudden ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
About this study. The purpose of this study is to assess the safety, tolerability, movement (pharmcokinetics, "PK"), biological response (pharmacodynamics, ...
Researchers in the Department of Biochemistry and Molecular Biology at Mayo Clinic are investigating potential treatments for metabolic diseases.
The purpose of this study is to determine how cystatin C, creatinine, and microalbuminuira change with gender affirming hormone therapy initiation. Blood draws ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.